Ampio Pharmaceuticals, Inc.
DelistedCIK 1411906fmd_05RTPTW8757C2TGQHJ0PAMWP6YManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2023, 56 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 1 | – | – | – | – | – | – | – | – |
| Net interest income | 0 | (0) | – | – | – | – | – | – | – | – |
| Cost of revenue | – | 0 | – | – | – | – | – | – | – | – |
| Gross profit | – | 1 | – | – | – | – | – | – | – | – |
| Research and development | 22 | 15 | 11 | – | 7 | 13 | 9 | 12 | 9 | 2 |
| Selling, general and administrative | 12 | 15 | – | – | – | – | – | – | – | – |
| Total operating expenses | 31 | 24 | 17 | 16 | 11 | 19 | 16 | 21 | 22 | 10 |
| Operating income | (39) | (33) | – | – | – | – | – | – | – | – |
| Interest expense | – | – | – | – | – | – | – | – | – | – |
| Interest and investment income | 0 | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | 0 | 0 | (2) | (36) | 45 | 5 | (0) | 3 | 6 | 1 |
| Income before taxes | – | – | – | – | – | – | – | – | – | – |
| Income tax expense | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Net income from continuing operations | (31) | (24) | (19) | (52) | – | – | – | – | – | – |
| Net income | (38) | (32) | (19) | (52) | 34 | (14) | (16) | (17) | (16) | (9) |
| Net income to common shareholders | – | – | – | – | (11) | (18) | (16) | (21) | (22) | (9) |